Related Experiment Videos
Selective expression of inducible nitric oxide synthase in human prostate carcinoma
Background:
Nitric oxide (NO) is synthesized by inducible nitric oxide synthase (iNOS) and plays an important role in tumor growth and angiogenesis. NO generation by iNOS also influences the cytotoxicity of macrophages and tumor-induced immunosuppression. Before now, the expression of iNOS in prostate carcinoma tissue had not been determined.
Methods:
In this study, tissue sections from 16 patients with prostate carcinoma were studied immunohistochemically and compared with tissue specimens from 10 patients with benign hyperplasia.
Results:
Positive iNOS immunostaining was detected in all sections from patients with prostate carcinoma. The malignant epithelial cells were highly positive. The antibody against iNOS also marked round cells, which had the same cell shape as that observed for macrophages. These cells were located in stroma and epithelium adjacent to tumor islets. However, round cells in benign tissue stained negative for iNOS. None of the benign hyperplasia specimens stained positive for iNOS immunohistochemically.
Conclusions:
Prostate carcinoma tissue had a high iNOS content, whereas benign tissue did not. The authors suggest that epithelial iNOS expression can be used as a specific immunohistochemical marker for prostate carcinoma. NO generation by iNOS may play multiple roles in the development of this disease.
Insights
Inducible nitric oxide synthase (iNOS) is highly expressed in prostate carcinoma tissue but not in benign tissue. This suggests iNOS may serve as a specific biomarker for prostate cancer detection.
Area of Science:
- Oncology
- Immunology
- Biochemistry
Background:
- Nitric oxide (NO) synthesized by inducible nitric oxide synthase (iNOS) is implicated in tumor growth, angiogenesis, and immune modulation.
- The role of iNOS in prostate carcinoma and its expression in tumor tissue were previously undetermined.
Purpose of the Study:
- To investigate the expression of iNOS in prostate carcinoma tissue.
- To determine if iNOS can serve as a specific marker for prostate cancer.
Main Methods:
- Immunohistochemical analysis of iNOS expression in prostate carcinoma tissue samples (n=16).
- Comparison with tissue specimens from patients with benign prostatic hyperplasia (n=10).
Main Results:
- All prostate carcinoma tissue sections exhibited positive iNOS immunostaining, particularly in malignant epithelial cells.
- Macrophages in the tumor microenvironment also showed positive iNOS staining.
- Benign hyperplasia tissue and associated cells showed no iNOS expression.
Conclusions:
- Prostate carcinoma tissue demonstrates significantly higher iNOS content compared to benign tissue.
- Epithelial iNOS expression is proposed as a specific immunohistochemical marker for prostate carcinoma.
- iNOS-derived NO likely plays a multifaceted role in prostate cancer development.